XML 37 R27.htm IDEA: XBRL DOCUMENT
v3.22.1

STOCK COMPENSATION PLANS | 12 Months Ended
--- | ---
Dec. 31, 2021
STOCK COMPENSATION PLANS |
STOCK COMPENSATION PLANS | 19. STOCK COMPENSATION PLANS The Company uses the modified prospective method for accounting for stock-based compensation and recognized $43,000 of compensation expense for the year 2021, $3,000 in 2020 and $7,000 in 2019. During 2021, the Company’s Board adopted, and its shareholders approved, the AmeriServ Financial, Inc. 2021 Equity Incentive Plan (the Plan) authorizing the grant of options or restricted stock covering 600,000 shares of common stock. This Plan replaced the expired 2011 Stock Incentive Plan. Under the Plan, options or restricted stock can be granted (the Grant Date) to directors, officers, and employees that provide services to the Company and its affiliates, as selected by the compensation committee of the Board. The option price at which a granted stock option may be exercised will not be less than 100% of the fair market value per share of common stock on the Grant Date. The maximum term of any option granted under the Plan cannot exceed 10 years. Generally, options vest over a three-year period and become exercisable in equal installments over the vesting period. At times, options with a one year vesting period may also be issued. A summary of the status of the Company’s Equity Incentive Plan at December 31, 2021, 2020, and 2019, and changes during the years then ended is presented in the table and narrative following: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | YEAR ENDED DECEMBER 31,
​ | ​ | 2021 | ​ | 2020 | ​ | 2019
​ |  | ​ |  | WEIGHTED |  | ​ |  | WEIGHTED |  | ​ |  | WEIGHTED
​ | ​ | ​ | ​ | AVERAGE | ​ | ​ | ​ | AVERAGE | ​ | ​ | ​ | AVERAGE
​ | ​ | SHARES | ​ | EXERCISE PRICE | ​ | SHARES | ​ | EXERCISE PRICE | ​ | SHARES | ​ | EXERCISE PRICE
Outstanding at beginning of year | ​ | 230,913 | ​ | $ | 3.14 | ​ | 296,648 | ​ | $ | 3.02 | ​ | 336,313 | ​ | $ | 2.91
Granted |  | 160,000 | ​ | ​ | 3.84 | ​ | — | ​ | ​ | — |  | 7,000 | ​ | ​ | 4.19
Exercised |  | (21,356) | ​ | ​ | 2.68 | ​ | (38,235) | ​ | ​ | 2.06 |  | (40,917) | ​ | ​ | 2.45
Forfeited |  | (510) | ​ | ​ | 3.23 | ​ | (27,500) | ​ | ​ | 3.30 |  | (5,748) | ​ | ​ | 2.44
Outstanding at end of year |  | 369,047 | ​ | ​ | 3.47 | ​ | 230,913 | ​ | ​ | 3.14 |  | 296,648 | ​ | ​ | 3.02
Exercisable at end of year |  | 206,713 | ​ | ​ | 3.18 | ​ | 224,580 | ​ | ​ | 3.11 |  | 282,565 | ​ | ​ | 2.96
Weighted average fair value of options granted in current year |  |  | ​ | $ | 1.78 | ​ |  | ​ | $ | — |  | ​ | ​ | $ | 0.62
​ A total of 206,713 of the 369,047 options outstanding at December 31, 2021, are exercisable and have exercise prices between $2.75 and $4.22, with a weighted average exercise price of $3.18 and a weighted average remaining contractual life of 2.71 years. The remaining 162,334 options that are not yet exercisable have exercise prices between $3.83 and $4.19, with a weighted average exercise price of $3.84 and a weighted average remaining contractual life of 9.11 years. The fair value of each option grant is estimated on the date of grant using the Binomial or Black-Scholes option pricing model with the following assumptions used for grants in 2021, 2020, and 2019. No stock options were granted during 2020. ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | YEAR ENDED DECEMBER 31, |
PRICING MODEL ASSUMPTION RANGES |  | 2021 |  | 2020 |  | 2019 |
Risk-free interest rate |  | 1.27 - 1.42 | % | — | % | 2.65 | %
Expected lives in years |  | 10 |  | — |  | 10 | ​
Expected volatility |  | 40.38 - 45.03 | % | — | % | 15.75 | %
Expected dividend rate |  | 2.60 - 2.61 | % | — | % | 1.91 | %
​ The intrinsic value of stock options exercised was $27,000, $56,000, and $71,000 in 2021, 2020, and 2019, respectively.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration